Trial Profile
Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism: AYKAN Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Pulmonary embolism
- Focus Adverse reactions
- Acronyms AYKAN
- 07 Feb 2014 New trial record